Xing-Li Zhou (Xingli Zhou)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 9

Top Topics

Monoclonal Antibody

Ulcerative Colitis

Top Venues

The Journal of dermatology

Dermatologic therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Xiwen Zhang, Yue Xiao, Xiaohong Li, Jinqiu Wang, Xing-Li Zhou, Yuxi Zhou, Mi Wang, Wei Li, Yiyi Wang
Ofatumumab subcutaneous injection successfully treated patients with pemphigus vulgaris relapse post rituximab. The Journal of dermatology (2024)
Xiwen Zhang, Yue Xiao, Xiaohong Li, Jinqiu Wang, Xing-Li Zhou, Yiyi Wang, Yuxi Zhou, Mi Wang, Wei Li
Ofatumumab subcutaneous injection successfully treated patients with pemphigus vulgaris relapse post rituximab. The Journal of dermatology 51 (7) (2024)
Xiwen Zhang, Yue Xiao, Xiaohong Li, Jinqiu Wang, Xing-Li Zhou, Yiyi Wang, Yuxi Zhou, Mi Wang, Wei Li
Ofatumumab subcutaneous injection successfully treated patients with pemphigus vulgaris relapse post rituximab. The Journal of dermatology 51 (7) (2024)
Xiwen Zhang, Yue Xiao, Xiaohong Li, Jinqiu Wang, Xing-Li Zhou, Yiyi Wang, Yuxi Zhou, Mi Wang, Wei Li
Ofatumumab subcutaneous injection successfully treated patients with pemphigus vulgaris relapse post rituximab. The Journal of dermatology (2024)
Xing-Li Zhou, Yuxi Zhou, Hua Qian, Fanglong Wu, Hongjie Liu, Xiaoguang Li, Wei Li
Anti-laminin γ1 (p200) pemphigoid successfully treated with tofacitinib combined with prednisone. The Journal of dermatology (2023)
Xing-Li Zhou, Jia Geng, Minjin Wang, Jinlin Yang, Jian Zou, Wei Li
Novel compound heterozygous mutations of the COL7A1 gene in a Chinese patient with recessive dystrophic epidermolysis bullosa pruriginosa and digestive symptoms successfully treated with tofacitinib. The Journal of dermatology (2023)
Xing-Li Zhou, Liangliang Cheng, Yiyi Wang, Hui Gou, Ke Ju, TianJiao Lan, Tongying Zhan, GaoJie Li, Yuanxia Gu, Yeting Sun, Yan Xu, Yukun Sun, Yanhong Zhou, Wei Li
Effect of NUDT15 polymorphisms on early hematological safety of low-dose azathioprine in Chinese patients with pemphigus vulgaris: A prospective cohort study. The Journal of dermatology (2021)
Xing-Li Zhou, Mi Wang, Sheng Wang, Xian Jiang, Wei Li
Identification of novel compound heterozygous ITGB4 mutations in a Chinese woman with junctional epidermolysis bullosa without pylori atresia but profound urinary symptoms: A case report and review of the literature. The Journal of dermatology 48 (11) (2021)
Xing-Li Zhou, Tong-Ying Zhan, Yan-Hong Zhou, Krista Shrestha, Tian-Jiao Lan, Wei Li
Complete remission of refractory pemphigus vulgaris in a Chinese patient with mutated NUDT15 by combination of minimal doses of azathioprine and prednisone. Dermatologic therapy 33 (6) (2020)